Christophe Lottin
Bioinformatics and system biology
R and D meat
France
Biography
With twenty years of experience in the field of cardiology, Christophe Lottin has risen through the ranks of the sales organization at Boston Scientific and Hexacath France, where he became Chairman with responsibilities in Benelux, Switzerland and Canada. . In particular, he played a key role in the commercial success of the Optimax Coronary Stent. His various positions led him to coordinate the critical services of a stent company and in particular R & D, clinical studies and regulatory affairs.
Research Interest
Bioinformatics and system biology
